2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]

      Life Sciences

      Elsevier Inc.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The author regrets that the article omitted to clarify that parts of Sections 2.1, 2.2, 3.1 and 3.2, as well as of Figs. 1 and 2 were reused from the article that was previously published by the author in Life Sciences 248 (2020) 117477 https://doi.org/10.1016/j.lfs.2020.117477. The author would like to apologise for any inconvenience caused.

          Related collections

          Author and article information

          Journal
          Life Sci
          Life Sci
          Life Sciences
          Elsevier Inc.
          0024-3205
          1879-0631
          28 August 2020
          1 October 2020
          28 August 2020
          : 258
          : 118350
          Affiliations
          Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt
          Article
          S0024-3205(20)31103-6 118350
          10.1016/j.lfs.2020.118350
          7957227
          32863005
          © 2020 Elsevier Inc. All rights reserved.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          Categories
          Corrigendum

          Comments

          Comment on this article